Having demonstrated that the direction of effect for the ZAP70 T155M risk variant is a partial loss of function, targeting ZAP70 kinase activity with inhibitors to treat autoimmunity could come with unanticipated consequences. The gene discussed is ZAP70; the disease is Autoimmunity.